![](https://monteverdelaw.com/wp-content/uploads/case-logo/avrobio-inc.png)
AVROBIO, Inc. (Nasdaq: AVRO), relating to its proposed merger with Tectonic Therapeutic, Inc. Under the terms of the agreement, AVRO shareholders are expected to own approximately 22.3% of the combined company.
AVROBIO, Inc. (Nasdaq: AVRO), relating to its proposed merger with Tectonic Therapeutic, Inc. Under the terms of the agreement, AVRO shareholders are expected to own approximately 22.3% of the combined company.